安普克
贾纳斯激酶
蛋白激酶A
AMP活化蛋白激酶
磷酸化
Janus激酶1
细胞生物学
激酶
化学
信号转导
ASK1
细胞周期蛋白依赖激酶2
癌症研究
生物
作者
Claire Rutherford,Claire Speirs,Jamie J.L. Williams,Marie‐Ann Ewart,Sarah J. Mancini,Simon A. Hawley,Christian Delles,Benoît Viollet,Ana P. Costa‐Pereira,George S. Baillie,Ian P. Salt,Timothy M. Palmer
出处
期刊:Science Signaling
[American Association for the Advancement of Science]
日期:2016-11-08
卷期号:9 (453): ra109-ra109
被引量:109
标识
DOI:10.1126/scisignal.aaf8566
摘要
abolished AMPK-mediated inhibition of JAK-STAT signaling stimulated by either the sIL-6Rα/IL-6 complex or the expression of a constitutively active V658F-mutant JAK1 in human fibrosarcoma cells. Clinically used AMPK activators metformin and salicylate enhanced the inhibitory phosphorylation of endogenous JAK1 and inhibited STAT3 phosphorylation in primary vascular endothelial cells. Therefore, our findings reveal a mechanism by which JAK1 function and inflammatory signaling may be suppressed in response to metabolic stress and provide a mechanistic rationale for the investigation of AMPK activators in a range of diseases associated with enhanced activation of the JAK-STAT pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI